Anti-SARS-CoV-2 hyperimmune globulin begins clinical trial

Read more

AMBAR results published in Alzheimer's & Dementia

Read more

Grifols is a global company that since 1909 has enhanced the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries.

Grifols Grifols